Protective role of LGP2 in influenza virus pathogenesis

Journal of Infectious Diseases

Volumn 210, Issue 2, 2014, Pages 214-223

  Si Tahar, Mustapha ^a,b,d   Blanc, Fany ^a,b   Furio, Laetitia ^a,b   Chopy, Damien ^a,c,e   Balloy, Viviane ^a,b   Lafon, Monique ^a,c   Chignard, Michel ^a,b   Fiette, Laurence ^a   Langa, Francina ^a   Charneau, Pierre ^a   Pothlichet, Julien ^a,b,f  

^a INSTITUT PASTEUR   (France)

^b Université Franaois Rabelais   (France)

^c CNRS UMR3569   (France)

^d Faculté de Médecine   (France)

^e Institut Roche de Recherche et Médecine Translationnelle Pharma Research and Early Development   (France)

^f CNRS   (France)

Author keywords

lung

Indexed keywords

LABORATORY OF GENETICS AND PHYSIOLOGY 2 PROTEIN; PATTERN RECOGNITION RECEPTOR; PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS; CONTROLLED STUDY; DOWN REGULATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLUENZA VIRUS A; LEUKOCYTE; LUNG ALVEOLUS; MOUSE; MOUSE MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SURVIVAL; TRANSGENIC MOUSE; VIRUS PATHOGENESIS; WILD TYPE;

IMMUNITY; INFLAMMATION; LUNG; SIGNAL TRANSDUCTION; VIRAL;

ANIMALS; DEAD-BOX RNA HELICASES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; RNA HELICASES; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84903954356     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu076     Document Type: Article

References (48)

1. Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol 2008; 3:499-522. (Pubitemid 351488291)
2. Thanh TT, van Doorn HR, de Jong MD. Human H5N1 influenza: current insight into pathogenesis. Int J Biochem Cell Biol 2008; 40:2671-4.
3. La Gruta NL, Kedzierska K, Stambas J, Doherty PC. A question of selfpreservation: immunopathology in influenza virus infection. Immunol Cell Biol 2007; 85:85-92. (Pubitemid 46398724)
4. Hayden F. Developing new antiviral agents for influenza treatment: what does the future hold? Clin Infect Dis 2009; 48 (Suppl 1):S3-13.
5. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20.
6. Chi H, Flavell RA. Innate recognition of non-self nucleic acids. Genome Biol 2008; 9:211.
7. Pothlichet J, Meunier I, Davis BK, et al. Type I IFN Triggers RIG-I/ TLR3/NLRP3-dependent Inflammasome Activation in Influenza A Virus Infected Cells. PLoS Pathog 2013; 9:e1003256.
8. Pothlichet J, Chignard M, Si-Tahar M. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCS1 and SOCS3 through a RIG-I/IFNAR1-dependent pathway. J Immunol 2008; 180:2034-8.
9. Le Goffic R, Pothlichet J, Vitour D, et al. Cutting Edge: Influenza Avirus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007; 178:3368-72. (Pubitemid 46417600)
10. Guillot L, Le Goffic R, Bloch S, et al. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005; 280:5571-80. (Pubitemid 40280035)
11. Le Goffic R, Balloy V, Lagranderie M, et al. Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2006; 2:e53.
12. Wang Y, Zhang HX, Sun YP, et al. Rig-I-/-mice develop colitis associated with downregulation of G alpha i2. Cell Res 2007; 17:858-68. (Pubitemid 47585114)
13. Kato H, Sato S, Yoneyama M, et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005; 23:19-28. (Pubitemid 41019654)
14. Vitour D, Meurs EF. Regulation of interferon production by RIG-I and LGP2: a lesson in self-control. Sci STKE 2007; 2007:pe20.
15. Childs KS, Randall RE, Goodbourn S. LGP2 plays a critical role in sensitizing mda-5 to activation by double-stranded RNA. PLoS One 2013; 8:e64202.
16. Rothenfusser S, Goutagny N, DiPerna G, et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acidinducible gene-I. J Immunol 2005; 175:5260-8. (Pubitemid 41456411)
17. Satoh T, Kato H, Kumagai Y, et al. LGP2 is a positive regulator of RIG-Iand MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A 2010; 107:1512-7.
18. Venkataraman T, Valdes M, Elsby R, et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol 2007; 178:6444-55. (Pubitemid 46717428)
19. Chopy D, Pothlichet J, Lafage M, et al. Ambivalent role of the innate immune response in rabies virus pathogenesis. J Virol 2011; 85:6657-68.
20. Suthar MS, Ramos HJ, Brassil MM, et al. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity 2012; 37:235-48.
21. Malur M, GaleMJr., Krug RM. LGP2 downregulates interferon production during infection with seasonal human influenza A viruses that activate interferon regulatory factor 3. J Virol 2012; 86:10733-8.
22. Pothlichet J, Burtey A, Kubarenko AV, et al. Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response. PLoS One 2009; 4:e7582.
23. Wikenheiser KA, Vorbroker DK, Rice WR, et al. Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/ simian virus 40 large tumor antigen transgenic mice. Proc Natl Acad Sci U S A 1993; 90:11029-33. (Pubitemid 23354362)
24. Guillot L, Medjane S, Le-Barillec K, et al. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2004; 279:2712-8. (Pubitemid 38114260)
25. Saito T, Hirai R, Loo YM, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 2007; 104:582-7. (Pubitemid 46123068)
26. Beignon AS, Mollier K, Liard C, et al. Lentiviral vector-based prime/ boost vaccination against AIDS: pilot study shows protection against Simian immunodeficiency virus SIVmac251 challenge in macaques. J Virol 2009; 83:10963-74.
27. Giannini C, Morosan S, Tralhao JG, et al. A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector. Hepatology 2003; 38:114-22. (Pubitemid 36775802)
28. Pothlichet J, Mangeney M, Heidmann T. Mobility and integration sites of a murine C57BL/6 melanoma endogenous retrovirus involved in tumor progression in vivo. Int J Cancer 2006; 119:1869-77. (Pubitemid 44356845)
29. Ikawa M, Tanaka N, Kao WW, Verma IM. Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy. Mol Ther 2003; 8:666-73. (Pubitemid 37321696)
30. Santoro MG, Rossi A, Amici C. NF-kappaB and virus infection: who controls whom. EMBO J 2003; 22:2552-60. (Pubitemid 36712353)
31. Song MS, Cho YH, Park SJ, et al. Early regulation of viral infection reduces inflammation and rescues mx-positive mice from lethal avian influenza infection. Am J Pathol 2013; 182:1308-21.
32. Kok WL, Denney L, Benam K, et al. Pivotal advance: invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune-pathology during severe influenza A virus infection. J Leukoc Biol 2012; 91:357-68.
33. Grommes J, Soehnlein O. Contribution of neutrophils to acute lung injury. Mol Med 2011; 17:293-307.
34. Lin KL, Sweeney S, Kang BD, Ramsburg E, GunnMD. CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection. J Immunol 2011; 186:508-15.
35. Belisle SE, Tisoncik JR, Korth MJ, et al. Genomic profiling of tumor necrosis factor alpha (TNF-alpha) receptor and interleukin-1 receptor knockout mice reveals a link between TNF-alpha signaling and increased severity of 1918 pandemic influenza virus infection. J Virol 2010; 84:12576-88.
36. Hussell T, Pennycook A, Openshaw PJ. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 2001; 31:2566-73. (Pubitemid 32898723)
37. Peper RL, Van Campen H. Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia. Microb Pathog 1995; 19:175-83.
38. Larrubia JR, Benito-Martinez S, Calvino M, Sanz-de-Villalobos E, Parra-Cid T. Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection. World J Gastroenterol 2008; 14:7149-59.
39. Maghazachi AA. Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 2010; 341:37-58.
40. Stanley ER, Berg KL, Einstein DB, et al. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 1997; 46:4-10. (Pubitemid 27021347)
41. Davatelis G, Tekamp-Olson P, Wolpe SD, et al. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J Exp Med 1988; 167:1939-44.
42. Wolpe SD, Davatelis G, Sherry B, et al. Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties. J Exp Med 1988; 167:570-81. (Pubitemid 18073655)
43. Xu LL, Warren MK, Rose WL, Gong W, Wang JM. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J Leukoc Biol 1996; 60:365-71. (Pubitemid 26325618)
44. Sarafi MN, Garcia-Zepeda EA, MacLean JA, Charo IF, Luster AD. Murine monocyte chemoattractant protein (MCP)-5: a novel CC chemokine that is a structural and functional homologue of human MCP-1. J Exp Med 1997; 185:99-109. (Pubitemid 27039445)
45. Jia GQ, Gonzalo JA, Lloyd C, et al. Distinct expression and function of the novel mouse chemokine monocyte chemotactic protein-5 in lung allergic inflammation. J Exp Med 1996; 184:1939-51. (Pubitemid 26404484)
46. Ishibashi O, Ali MM, Luo SS, et al. Short RNA duplexes elicit RIG-Imediated apoptosis in a cell type-and length-dependent manner. Sci Signal 2011; 4:ra74.
47. Sakai S, Kawamata H, Mantani N, et al. Therapeutic effect of anti-macrophage inflammatory protein 2 antibody on influenza virus-induced pneumonia in mice. J Virol 2000; 74:2472-6. (Pubitemid 30091507)
48. Walter U, Santamaria P. CD8+ T cells in autoimmunity. Curr Opin Immunol 2005; 17:624-31.